Asymptomatic screening for SARS CoV-2 prior to commencement of biologic therapies in patients with inflammatory bowel disease - a potentially harmful practice.

Detalles Bibliográficos
Autores principales: Prentice, Ralley E., Al-Ani, Aysha H, Bond, Katherine, Johnson, Doug, Christensen, Britt
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Ltd on behalf of Editrice Gastroenterologica Italiana S.r.l. 2020
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7450924/
https://www.ncbi.nlm.nih.gov/pubmed/32928674
http://dx.doi.org/10.1016/j.dld.2020.08.035

Ejemplares similares

Ejemplares similares